Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Increasing Prevalence of Obesity
The increasing prevalence of obesity is one of the main reasons driving the growth of the market. Owing to a lack of inactivity, deskbound jobs, alcohol consumption, and unhealthy eating habits, a significant portion of the world's population is suffering from weight-related health concerns. Thus, many physicians advice patients to lose weight, and overweight and obese people opt for the intragastric balloons method, as it serves as an effective non-surgical procedure. As per the Central Intelligence Agency World Factbook, the UAE has an obesity prevalence rate of 31.7%.Preference Towards Non-Surgical and Non-Invasive Procedures
Nowadays, due to an increase in awareness among the masses regarding weight-loss procedures, obese and overweight adults prefer non-surgical and non-invasive treatments, including intragastric balloons. Intragastric balloons serve as an effective non-surgical substitute for weight loss as they are inserted orally and do not require any incisions on the body. Also, it has a fast recovery rate with less discomfort. Likewise, the growing preference for non-invasive surgeries is bolstering market growth.Technological Advancements
Technological advancements and product innovations are the key factors influencing the market. Manufacturers are focusing on creating product variants with minimal side effects, such as gastric erosion, ulceration, and nausea. The advancements are made in intragastric balloons by coupling dual and triple balloons to prevent the migration of the device from the stomach to the intestine, thus, in turn, reducing the risk of intestinal obstruction. They are also designing balloons with adjustable gas/saline volumes. In UAE, allurion Technologies announced the availability of its Gastric Balloon technology for people with age between 16 to 65 years in selected clinics, and it is the first and only weight loss tool in the world without surgery, endoscopy, or anesthesia.Market Segmentation
The UAE Intragastric balloons market is segmented into administration, balloon type, filling type, application, end-user, and company. Based on administration, the market is divided into pill form and endoscopy. Based on balloon type, the market is divided into single, dual, and triple. Based on filling type, the market is divided into saline-filled and gas-filled. Based on application, the market is divided into obesity, diabetes, diet control, and others. Based on end-user, the market is divided into hospitals & clinics, ambulatory surgical centers, and others. In terms of region, the market is segmented into Abu Dhabi, Dubai, Sharjah, and Rest of UAE.Market Players
Obalon Therapeutics, Inc. (UAE), Allurion Technologies, Inc. (UAE), ReShape Lifesciences Inc (UAE), Silimed Inc. (UAE), Allergan Middle East Limited, Vasmed UAE, and Life Mate Medical Equipment Trading LLC are some of the leading companies operating in the market.
Report Scope:
In this report, UAE intragastric balloons market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:UAE Intragastric balloons Market, By Administration:
- Pill Form
- Endoscopy
UAE Intragastric Balloons Market, By Balloon Type:
- Single
- Dual
- Triple
UAE Intragastric balloons Market, By Filling Type:
- Saline Filled
- Gas Filled
UAE Intragastric balloons Market, By Application:
- Obesity
- Diabetes
- Diet Control
- Others
UAE Intragastric balloons Market, By End User:
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
UAE Intragastric balloons Market, By Region:
- Abu Dhabi
- Dubai
- Sharjah
- Rest of UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Intragastric balloons market.Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Obalon Therapeutics, Inc. (UAE)
- Allurion Technologies, Inc. (UAE)
- ReShape Lifesciences Inc (UAE)
- Silimed Inc. (UAE)
- Allergan Middle East Limited
- Vasmed UAE
- Life Mate Medical Equipment Trading LLC